{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:39:26Z","timestamp":1794472766216,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Small Business Research from Innovation Zone of Quzhou City, Zhejiang, China"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.08.043","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T07:55:08Z","timestamp":1566892508000},"page":"6060-6067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects"],"prefix":"10.1016","volume":"37","author":[{"given":"Rongqing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1489-0246","authenticated-orcid":false,"given":"Pengcheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagarajan","family":"Thirumeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maohua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshuang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.043_b0005","first-page":"1","article-title":"Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure","volume":"2","author":"Tarantola","year":"2017","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.vaccine.2019.08.043_b0010","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1099\/0022-1317-71-8-1689","article-title":"Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein","volume":"71","author":"Lafon","year":"1990","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.08.043_b0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/viro.1995.0049","article-title":"Immune effector mechanisms required for protection to rabies virus","volume":"214","author":"Xiang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.08.043_b0020","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.08.043_b0025","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2460\/javma.1998.212.08.1198","article-title":"Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990\u20131996)","volume":"212","author":"Rotz","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2019.08.043_b0030","unstructured":"WHO. WHO expert consultation on rabies. Third report. Geneva, Switzerland: World Health Organization; 2018. p. 121."},{"key":"10.1016\/j.vaccine.2019.08.043_b0035","first-page":"1092","article-title":"Manual of diagnostic tests and vaccines for terrestrial animals","author":"Oie","year":"2015","journal-title":"Bull Off Int Epizoot"},{"key":"10.1016\/j.vaccine.2019.08.043_b0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3181\/00379727-32-7767P","article-title":"Early diagnosis of rabies by mouse inoculation. Measurement of humoral immunity to rabies by mouse protection test","volume":"32","author":"Webster","year":"1935","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2019.08.043_b0045","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.08.043_b0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2019.08.043_b0055","doi-asserted-by":"crossref","unstructured":"Messenger S, Rupprecht CE. An indirect fluorescent antibody test for the serological detection of rabies virus immunoglobulin G and immunoglobulin M antibodies. In: Rupprecht CE, Nagarajan T, editors. Chapter 14. Current laboratory techniques in rabies diagnosis research & prevention. 1st ed. vol 2. USA: Academic Press; 2015. p. 157\u201373.","DOI":"10.1016\/B978-0-12-801919-1.00014-2"},{"key":"10.1016\/j.vaccine.2019.08.043_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2006.02.011","article-title":"Collaborative study to evaluate a new ELISA test to monitor the effectiveness of rabies vaccination in domestic carnivores","volume":"120","author":"Servat","year":"2006","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2019.08.043_b0065","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.043_b0070","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.vaccine.2009.01.126","article-title":"Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs","volume":"27","author":"Zhang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.043_b0075","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jviromet.2012.11.022","article-title":"Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field","volume":"187","author":"Wasniewski","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2019.08.043_b0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-1157(86)90027-2","article-title":"The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus","volume":"14","author":"Perrin","year":"1986","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2019.08.043_b0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jviromet.2010.09.002","article-title":"A rapid immunochromatographic test strip for detecting rabies virus antibody","volume":"170","author":"Wang","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2019.08.043_b0090","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.08.043_b0095","first-page":"891","article-title":"Effect of pH value on stability of recombinant human anti-rabies monoclonal antibody","volume":"22","author":"Li","year":"2009","journal-title":"Chinese J Biol"},{"key":"10.1016\/j.vaccine.2019.08.043_b0100","first-page":"10","article-title":"Collaborative study for the establishment of human rabies immunoglobulin Biological Reference Preparation batch no. 1","volume":"99","author":"Zwahlen","year":"1999","journal-title":"Pharmeuropa Bio"},{"key":"10.1016\/j.vaccine.2019.08.043_b0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characterisitc curves: a non-parametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.vaccine.2019.08.043_b0110","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.vaccine.2019.08.043_b0115","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2460\/javma.1996.208.11.1827","article-title":"Postexposure rabies prophylaxis and preexposure rabies vaccination failure in domestic animals","volume":"208","author":"Clark","year":"1996","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2019.08.043_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biologicals.2005.06.005","article-title":"The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays","volume":"33","author":"Moore","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.08.043_b0125","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus infection and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.043_b0130","doi-asserted-by":"crossref","first-page":"735","DOI":"10.20506\/rst.11.3.622","article-title":"Practical significance of rabies antibodies in cats and dogs","volume":"11","author":"Aubert","year":"1992","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2019.08.043_b0135","first-page":"601789","article-title":"Using intradermal rabies vaccine to boost immunity in people with low rabies antibody levels","author":"Brown","year":"2011","journal-title":"Adv Prev Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:19:47Z","timestamp":1721650787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":27,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19311077"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}